Edgewise Therapeutics Inc (EWTX)

Mar 13, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.3%Time to Sell? - MarketBeat

Mar 13, 2025

Mar 12, 2025

Ratios Uncovered: Breaking Down Edgewise Therapeutics Inc (EWTX)’s Trailing Twelve Months Metrics - The Dwinnex

Mar 12, 2025

Mar 12, 2025

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference - BioSpace

Mar 12, 2025

Mar 12, 2025

Edgewise Therapeutics chief scientific officer sells $6,004 in stock By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 12, 2025

Edgewise Therapeutics CEO Kevin Koch sells $3,000 in stock By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Scotiabank Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat

Mar 11, 2025

Mar 11, 2025

Edgewise Therapeutics chief scientific officer sells $6,004 in stock - Investing.com

Mar 11, 2025

Mar 11, 2025

Breakthrough Drug Sevasemten Delivers Positive Results for Becker Muscular Dystrophy Patients - StockTitan

Mar 11, 2025

Mar 11, 2025

Investors Buy Large Volume of Edgewise Therapeutics Call Options (NASDAQ:EWTX) - MarketBeat

Mar 11, 2025

Mar 11, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Trading Up 4.9%Still a Buy? - MarketBeat

Mar 11, 2025

Mar 10, 2025

Edgewise Therapeutics: More Expensive Now, But Much More Derisked (NASDAQ:EWTX) - Seeking Alpha

Mar 10, 2025

Mar 10, 2025

Piper Sandler maintains $51 target on Edgewise Therapeutics stock By Investing.com - Investing.com Canada

Mar 10, 2025

Mar 10, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock Holdings Lessened by Candriam S.C.A. - MarketBeat

Mar 10, 2025

Mar 10, 2025

Why Is Edgewise Therapeutics Inc (NASDAQ: EWTX) Falling? - Stocks Register

Mar 10, 2025

Mar 10, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Research Coverage Started at Scotiabank - Defense World

Mar 10, 2025

Mar 09, 2025

Trend Tracker for (EWTX) - Stock Traders Daily

Mar 09, 2025

Mar 09, 2025

Q1 EPS Forecast for Edgewise Therapeutics Lowered by Analyst - MarketBeat

Mar 09, 2025

Mar 09, 2025

Equities Analysts Issue Forecasts for EWTX FY2026 Earnings - MarketBeat

Mar 09, 2025

Mar 08, 2025

Scotiabank Initiates Coverage of Edgewise Therapeutics (EWTX) with Sector Outperform Recommendation - Nasdaq

Mar 08, 2025

Mar 08, 2025

Edgewise Therapeutics Sees Unusually High Options Volume (NASDAQ:EWTX) - Defense World

Mar 08, 2025

Mar 07, 2025

Edgewise Therapeutics' (EWTX) Outperform Rating Reiterated at Royal Bank of Canada - MarketBeat

Mar 07, 2025

Mar 07, 2025

Scotiabank sets $50 target for Edgewise Therapeutics stock - Investing.com India

Mar 07, 2025

Mar 07, 2025

Wedbush Lowers Earnings Estimates for Edgewise Therapeutics - Defense World

Mar 07, 2025

Mar 07, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat

Mar 07, 2025

Mar 06, 2025

Leerink Partnrs Brokers Decrease Earnings Estimates for EWTX - Defense World

Mar 06, 2025

Mar 06, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Announces Quarterly Earnings Results - MarketBeat

Mar 06, 2025

Mar 05, 2025

Handelsbanken Fonder AB Purchases Shares of 21,800 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Mar 05, 2025

Mar 05, 2025

Ratios Revealed: Decoding Edgewise Therapeutics Inc (EWTX)’s Financial Health - The Dwinnex

Mar 05, 2025

Mar 05, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Receives Outperform Rating from Royal Bank of Canada - Defense World

Mar 05, 2025

Mar 04, 2025

Edgewise Therapeutics to Present at the Leerink Partners Global Healthcare Conference on March 11, 2025 - Joplin Globe

Mar 04, 2025

Mar 03, 2025

Edgewise Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 03, 2025

Mar 03, 2025

Edgewise Therapeutics boosted R&D spending in final quarter of 2024 - BizWest

Mar 03, 2025

Mar 03, 2025

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Total Operating Expenses $45.5M - Marketscreener.com

Mar 03, 2025

Mar 03, 2025

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Net Loss $0.42 a Share, vs. FactSet Est of $0.37 Loss - Marketscreener.com

Mar 03, 2025

Mar 03, 2025

Edgewise Therapeutics reports Q4 EPS (42c), consensus (42c) - TipRanks

Mar 03, 2025

Mar 03, 2025

Edgewise Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 03, 2025

Mar 03, 2025

Edgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - Business Wire

Mar 03, 2025

Mar 03, 2025

Can Edgewise's $470M War Chest and Muscular Dystrophy Pipeline Deliver for Biotech Investors? - StockTitan

Mar 03, 2025

Mar 02, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Mar 02, 2025

Mar 02, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 02, 2025

Feb 25, 2025

Edgewise Therapeutics (EWTX) Shares Cross Below 200 DMA - Nasdaq

Feb 25, 2025

Feb 24, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.9% HigherShould You Buy? - MarketBeat

Feb 24, 2025

Feb 23, 2025

Edgewise Therapeutics (EWTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 23, 2025